These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 14577021)

  • 21. A randomized, prospective, pharmacoeconomic trial of neoral 2-hour postdose concentration monitoring versus tacrolimus trough concentration monitoring in de novo liver transplant recipients.
    Shenoy S; Hardinger KL; Crippin J; Korenblat K; Lisker-Melman M; Lowell JA; Chapman W
    Liver Transpl; 2008 Feb; 14(2):173-80. PubMed ID: 18236391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of oral cyclosporine (Neoral) in heart transplant recipients during the immediate period after surgery.
    Banner NR; David OJ; Leaver N; Davis J; Breen J; Johnston A; Yacoub MH
    Transpl Int; 2002 Dec; 15(12):649-54. PubMed ID: 12478413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Abbreviated cyclosporine AUCs on Neoral--the search continues!
    Filler G; Mai I; Filler S; Ehrich JH
    Pediatr Nephrol; 1999 Feb; 13(2):98-102. PubMed ID: 10228992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The relative importance of cyclosporine exposure in heart, kidney or liver transplant recipients on maintenance therapy.
    Hesselink DA; van Dam T; Metselaar HJ; Balk AH; Mathôt RA; Smak Gregoor PJ; Weimar W; van Gelder T
    Transpl Int; 2004 Oct; 17(9):495-504. PubMed ID: 15338117
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of cyclosporine in recipients of marginal versus standard liver transplants.
    Casale F; Lupo F; Passera R; Liddo G; Moscato D; Mosso R; Zara GP; Eandi M; Salizzoni M
    Pharmacol Res; 2006 Oct; 54(4):287-92. PubMed ID: 16884914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monitoring C2 level predicts exposure in maintenance lung transplant patients receiving the microemulsion formulation of cyclosporine (Neoral).
    Jaksch P; Kocher A; Neuhauser P; Sarahrudi K; Seweryn J; Wisser W; Klepetko W
    J Heart Lung Transplant; 2005 Aug; 24(8):1076-80. PubMed ID: 16102443
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical success of Neoral absorption profile.
    Uchida K; Tominaga Y; Haba T; Katayama A; Matsuoka S; Goto N; Ueki T; Kimata T; Takeda A; Morozumi K; Takagi H; Nakao A
    Transplant Proc; 2004 Mar; 36(2 Suppl):461S-464S. PubMed ID: 15041388
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MDR1 C3435T polymorphisms correlate with cyclosporine levels in de novo renal recipients.
    Foote CJ; Greer W; Kiberd BA; Fraser A; Lawen J; Nashan B; Belitsky P
    Transplant Proc; 2006 Nov; 38(9):2847-9. PubMed ID: 17112845
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determination of area under the whole blood concentration versus time curve after first intravenous cyclosporine dose in children undergoing hematopoietic stem cell transplant: limited sampling strategies.
    Sibbald C; Seto W; Taylor T; Saunders EF; Doyle J; Dupuis LL
    Ther Drug Monit; 2008 Aug; 30(4):434-8. PubMed ID: 18641547
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between the dose and whole blood level of cyclosporine after liver and kidney transplantation.
    Kahn D; Cervio G; Mazzaferro V; Venkataramanan R; Makowka L; Van Thiel DH; Starzl TE
    J Clin Lab Immunol; 1992; 37(4):163-71. PubMed ID: 1339916
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclosporine pharmacokinetics and blood pressure responses after conversion to once-daily dosing in maintenance liver transplant patients.
    Kovarik JM; Villamil F; Otero A; Levy G; Lynch S; Cillo U; Fischer L; Nashan B; Pollard S; De Carlis L
    Clin Transplant; 2008; 22(1):68-75. PubMed ID: 18217908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of late conversion from C0 to C2 monitoring of microemulsified cyclosporine in pediatric living donor liver transplant recipients.
    Takatsuki M; Chen CL; Chen YS; Wang CC; Lin CC; Yang CH; Yong CC; Liu YW
    Clin Transplant; 2004 Dec; 18(6):694-9. PubMed ID: 15516246
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A limited sampling strategy for the estimation of 12-hour cyclosporine neoral area under the curve in Chinese cardiac transplant recipients.
    Wang CH; Ko WJ; Chou NK; Wang SS
    Transplant Proc; 2004 Oct; 36(8):2390-2. PubMed ID: 15561259
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The area under the concentration-time curve versus trough and peak blood level monitoring in renal transplant recipients on cyclosporine.
    Halim MA; Nampoory MR; Johny KV; Donia F; Hamid MH; Said T; Nair MP; Mansour M; Al-Muzairai I; Samhan M; Al-Mousawi M
    Transplant Proc; 2005 Sep; 37(7):3019-21. PubMed ID: 16213291
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New concepts in cyclosporine monitoring.
    Keown PA
    Curr Opin Nephrol Hypertens; 2002 Nov; 11(6):619-26. PubMed ID: 12394607
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic drug monitoring of cyclosporine Neoral in de novo Chinese cardiac transplant recipients treated with an everolimus-cyclosporine immunosuppressive regimen.
    Wang CH; Chou NK; Wu FL; Ko WJ; Tsao CI; Chi NH; Hsu RB; Wang SS
    Transplant Proc; 2006 Sep; 38(7):2132-4. PubMed ID: 16980022
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Experience with conversion from Sandimmun to Neoral cyclosporine and the correlation of C2 levels with renal function.
    Konstadinidou I; Boletis JN
    Transplant Proc; 2004 Mar; 36(2 Suppl):163S-166S. PubMed ID: 15041329
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does cholestyramine interfere with cyclosporine absorption? A prospective study in renal transplant patients.
    Jensen RA; Lal SM; Diaz-Arias A; James-Kracke M; Van Stone JC; Ross G
    ASAIO J; 1995; 41(3):M704-6. PubMed ID: 8573896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circadian variations in cyclosporine C2 concentrations during the first 2 weeks after liver transplantation.
    Baraldo M; Risaliti A; Bresadola F; Chiarandini P; Dalla Rocca G; Furlanut M
    Transplant Proc; 2003 Jun; 35(4):1449-51. PubMed ID: 12826188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical outcomes and C2 cyclosporin monitoring in maintenance renal transplant recipients: 1 year follow-up study.
    Marcén R; Villafruela JJ; Pascual J; Teruel JL; Ocaña J; Tenorio MT; Burgos FJ; Ortuño J
    Nephrol Dial Transplant; 2005 Apr; 20(4):803-10. PubMed ID: 15687111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.